Vaccinex, Inc.

VCNX · OTC
Analyze with AI
12/31/2024
9/30/2024
6/30/2024
3/31/2024
Operating Activities
Net Income-$3,374-$5,732-$5,631-$3,897
Dep. & Amort.$17$24$26$27
Deferred Tax$0$0$0$0
Stock-Based Comp.$57$76$112$96
Change in WC-$646$1,248$1,153$348
Other Non-Cash$14$1,177-$75-$1,206
Operating Cash Flow-$3,932-$3,207-$4,415-$4,632
Investing Activities
PP&E Inv.$0-$8-$14$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0-$8-$14$0
Financing Activities
Debt Repay.-$18-$32-$7-$19
Stock Issued$2,150$5,920$1,697$4,975
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$0$0$1,113
Financing Cash Flow$2,133$5,888$1,690$6,069
Forex Effect$0$0$0$0
Net Chg. in Cash-$1,799$2,673-$2,739$1,437
Supplemental Information
Beg. Cash$2,906$233$2,972$1,535
End Cash$1,107$2,906$233$2,972
Free Cash Flow-$3,932-$3,215-$4,429-$4,632
Vaccinex, Inc. (VCNX) Financial Statements & Key Stats | AlphaPilot